Jianming He
12PUBLICATIONS
17CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (12)
Sort by Publication Date:
|Aug 12, 2025
Identification of treatment effect modifiers and prognostic factors in newly diagnosed and relapsed or refractory multiple myeloma.Jianming He, Karen Chiang, Xiwu Lin
|Aug 07, 2024
Real-world treatment patterns and outcomes in relapsed/refractory multiple myeloma (1-3 prior lines): Flatiron database.Binod Dhakal, Hermann Einsele, Jordan M Schecter
|Jul 25, 2022
Indirect Treatment Comparison of Daratumumab, Pomalidomide, and Dexamethasone Versus Standard of Care in Patients with Difficult-to-Treat Relapsed/Refractory Multiple Myeloma.Jianming He, Heather Berringer, Bart Heeg
|Jul 18, 2022
Comparative efficacy and safety of bortezomib, thalidomide, and dexamethasone (VTd) without and with daratumumab (D-VTd) in CASSIOPEIA versus VTd in PETHEMA/GEM in transplant-eligible patients with newly diagnosed multiple myeloma, using propensity score matching.Philippe Moreau, Cyrille Hulin, Sonja Zweegman
|Jul 18, 2022
Matching-adjusted indirect comparison of efficacy and safety of bortezomib, thalidomide, and dexamethasone (VTd) as per label compared with modified VTd dosing schedules in patients with newly diagnosed multiple myeloma who are transplant eligible.Pieter Sonneveld, María-Victoria Mateos, Adrian Alegre
|Mar 17, 2021
A systematic review of noninferiority margins in oncology clinical trials.Mahmoud Hashim, Talitha Vincken, Florint Kroi
Pageof 2
Frequent Collaborators
2 joint publications
Maria-Victoria Mateos
2 joint publications
William Deraedt
1 joint publications
Jesus San-Miguel
1 joint publications
Hartmut Goldschmidt
1 joint publications
Pieter Sonneveld
1 joint publications
Meletios A Dimopoulos
1 joint publications
Bart Heeg
1 joint publications
Mahmoud Hashim
1 joint publications
Peter Hu
1 joint publications
Annette Lam
